Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 793
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Excenel Evo 50 mg/ml V/MRP/11/0055 Zoetis Belgium S.A., Beļģija QJ01DD90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Ceftiofur (as ceftiofur hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 04-Oct-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Nov-2024)
Summary of product characteristics: [PDF] Zāļu_informācija_ZA_M_LI (22-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/11/0055-01 50 mg/ml 1 Stikla pudelīte, 50 ml -
V/MRP/11/0055-02 50 mg/ml 10 Stikla pudelīte, 50 ml -
V/MRP/11/0055-03 50 mg/ml 1 Stikla pudelīte, 100 ml -
V/MRP/11/0055-04 50 mg/ml 10 Stikla pudelīte, 100 ml -
V/MRP/11/0055-05 50 mg/ml 1 Stikla flakons, 250 ml -
Pulmovet 250 mg/ml V/DCP/18/0030 Dopharma Research B.V., Nīderlande QJ01FA91 cattle; pigs; turkeys; chickens Vairāk

Medicinal product information

Pharmaceutical form: solution for use in drinking water or milk replacer
International name (active substance): Tilmicosin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Oct-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Oct-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Jul-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0030-01 1 ABPE pudele, 960 ml -
V/DCP/18/0030-02 1 Polietilēna kanna, 5040 ml -
EFFIPRO 402 mg/pipetē V/DCP/22/0033 Virbac S.A., Francija QP53AX15 very large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Virbac S.A., Francija
Date of authorisation/renewal: 26-Jul-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Apr-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Apr-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Apr-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0033-01 402 mg/pipetē 1 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-02 402 mg/pipetē 2 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-03 402 mg/pipetē 3 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-04 402 mg/pipetē 4 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-05 402 mg/pipetē 6 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-06 402 mg/pipetē 8 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-07 402 mg/pipetē 12 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-08 402 mg/pipetē 24 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-09 402 mg/pipetē 30 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-10 402 mg/pipetē 60 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-11 402 mg/pipetē 90 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-12 402 mg/pipetē 150 Plastmasas pipete, 4,02 ml -
V/DCP/22/0033-13 402 mg/pipetē 1 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-14 402 mg/pipetē 2 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-15 402 mg/pipetē 3 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-16 402 mg/pipetē 4 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-17 402 mg/pipetē 6 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-18 402 mg/pipetē 8 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-19 402 mg/pipetē 12 Termoformēta pipete, 4,02 ml -
V/DCP/22/0033-20 402 mg/pipetē 24 Termoformēta pipete, 4,02 ml -
Thyroxanil vet 200 µg V/DCP/16/0010 Le Vet Beheer B.V., Nīderlande QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lindopharm GmbH, Vācija;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 24-Feb-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 300316LI (24-Feb-2021)
Labelling text: [DOCX] 300316M (24-Feb-2021)
Summary of product characteristics: [DOCX] 300316ZA (24-Feb-2021)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0010-01 200 µg 1 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-02 200 µg 2 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-03 200 µg 3 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-04 200 µg 4 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-05 200 µg 5 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-06 200 µg 6 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-07 200 µg 7 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-08 200 µg 8 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-09 200 µg 9 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-10 200 µg 10 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0010-11 200 µg 1 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-12 200 µg 2 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-13 200 µg 3 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-14 200 µg 4 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-15 200 µg 5 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-16 200 µg 6 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-17 200 µg 7 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-18 200 µg 8 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-19 200 µg 9 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0010-20 200 µg 10 Aclar/PVH blisteris, 30 tablete -
Thyroxanil vet 600 µg V/DCP/16/0011 Le Vet Beheer B.V., Nīderlande QH03AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Levothyroxine sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lindopharm GmbH, Vācija;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 24-Feb-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 300316LI (24-Feb-2021)
Labelling text: [DOCX] 300316M (24-Feb-2021)
Summary of product characteristics: [DOCX] 300316ZA (24-Feb-2021)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0011-01 600 µg 1 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-02 600 µg 2 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-03 600 µg 3 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-04 600 µg 4 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-05 600 µg 5 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-06 600 µg 6 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-07 600 µg 7 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-08 600 µg 8 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-09 600 µg 9 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-10 600 µg 10 Aclar/PVH blisteris, 25 tablete -
V/DCP/16/0011-11 600 µg 1 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-12 600 µg 2 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-13 600 µg 3 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-14 600 µg 4 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-15 600 µg 5 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-16 600 µg 6 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-17 600 µg 7 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-18 600 µg 8 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-19 600 µg 9 Aclar/PVH blisteris, 30 tablete -
V/DCP/16/0011-20 600 µg 10 Aclar/PVH blisteris, 30 tablete -
Vetmedin 2.5 mg V/DCP/11/0011 Boehringer Ingelheim Vetmedica GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Meda Manufacturing GmbH, Vācija;Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal: 21-Mar-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/11/0011-01 2,5 mg 1 Polipropilēna flakons, 50 tablete -
Vetmedin 5 mg V/DCP/11/0012 Boehringer Ingelheim Vetmedica GmbH, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Meda Manufacturing GmbH, Vācija;Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal: 21-Mar-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-May-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/11/0012-01 5 mg 1 Polipropilēna flakons, 50 tablete -
Nalgosed 10 mg/ml V/MRP/18/0021 Bioveta, a.s., Čehija QN02AF01 horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Butorphanol
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 21-May-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 210521LI (21-May-2021)
Labelling text: [DOCX] 210521M (21-May-2021)
Summary of product characteristics: [DOCX] 30072024ZA (30-Jul-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0021-01 1 Stikla flakons, 10 ml -
BioBos IBR marker inact. - V/MRP/14/0003 Bioveta, a.s., Čehija QI02AA03 cattle Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated Bovine herpesvirus type 1 (BHV-1), strain Bio-27
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 02-Feb-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Dec-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/14/0003-01 10 Stikla flakons, 5 deva -
V/MRP/14/0003-02 1 Stikla flakons, 5 deva -
V/MRP/14/0003-03 1 Stikla flakons, 25 deva -
V/MRP/14/0003-04 1 Stikla flakons, 50 deva -
V/MRP/14/0003-05 1 ABPE flakons, 50 deva -
V/MRP/14/0003-06 1 ABPE flakons, 25 deva -
Milprazon CHEWABLE 4 mg/10 mg - V/MRP/19/0011 KRKA, d.d., Novo mesto, Slovēnija QP54AB51 small cats; kittens weighing at least 0.5 kg Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA d.d. Novo Mesto, Slovēnija
Date of authorisation/renewal: 02-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/19/0011-01 4/10 mg 1 Al/OPA/Al/PVH blisteris, 2 tablete -
V/MRP/19/0011-02 4/10 mg 1 Al/OPA/Al/PVH blisteris, 4 tablete -
V/MRP/19/0011-03 4/10 mg 12 Al/OPA/Al/PVH blisteris, 4 tablete -
Clavaseptin 50 mg - V/MRP/11/0035 Vetoquinol S.A., Francija QJ01CR02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: palatable tablets
International name (active substance): Amoxicillin trihydrate,Clavulanic acid
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 31-Oct-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Dec-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/11/0035-01 1 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-02 2 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-03 5 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-04 10 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-05 12 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-06 15 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-07 20 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-08 25 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-09 30 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-10 40 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-11 50 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-12 60 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-13 75 Alumīnija blisteris, 10 tablete -
V/MRP/11/0035-14 100 Alumīnija blisteris, 10 tablete -
HIPRA GUMBORO CW - V/MRP/18/0044 Laboratorios Hipra S.A., Spānija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for use in drinking water
International name (active substance): Live attenuated Infectious Bursal Disease Virus, strain CH/80
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Nov-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Nov-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-Nov-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0044-01 1 Stikla flakons, 1000 deva -
V/MRP/18/0044-02 1 Stikla flakons, 5000 deva -
V/MRP/18/0044-03 1 Stikla flakons, 10000 deva -
V/MRP/18/0044-04 10 Stikla flakons, 1000 deva -
V/MRP/18/0044-05 10 Stikla flakons, 5000 deva -
V/MRP/18/0044-06 10 Stikla flakons, 10000 deva -
Metomotyl 2.5 mg/ml V/DCP/14/0036 Le Vet Beheer B.V., Nīderlande QA03FA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Metoclopramide hydrochloride monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 01-Oct-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0036-01 2,5 mg/ml 1 Stikla pudele, 5 ml -
V/DCP/14/0036-02 2,5 mg/ml 1 Stikla pudele, 10 ml -
V/DCP/14/0036-03 2,5 mg/ml 1 Stikla pudele, 20 ml -
V/DCP/14/0036-04 2,5 mg/ml 1 Stikla pudele, 25 ml -
V/DCP/14/0036-05 2,5 mg/ml 1 Stikla pudele, 30 ml -
V/DCP/14/0036-06 2,5 mg/ml 1 Stikla pudele, 50 ml -
Metomotyl 5 mg/ml V/DCP/14/0037 Le Vet Beheer B.V., Nīderlande QA03FA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Metoclopramide hydrochloride monohydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 01-Oct-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0037-01 5 mg/ml 1 Stikla flakons, 5 ml -
V/DCP/14/0037-02 5 mg/ml 1 Stikla flakons, 10 ml -
V/DCP/14/0037-03 5 mg/ml 1 Stikla flakons, 20 ml -
V/DCP/14/0037-04 5 mg/ml 1 Stikla flakons, 25 ml -
V/DCP/14/0037-05 5 mg/ml 1 Stikla flakons, 30 ml -
V/DCP/14/0037-06 5 mg/ml 1 Stikla flakons, 50 ml -
Finilac vet 50 µg/ml V/DCP/15/0002 Le Vet Beheer B.V., Nīderlande QG02CB03 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Cabergoline
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dreluso Pharmazeutika Dr. Elten & Sohn, Vācija
Date of authorisation/renewal: 28-Apr-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Oct-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Oct-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Oct-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0002-01 50 µg/ml 1 Stikla pudele, 3 ml -
V/DCP/15/0002-02 50 µg/ml 1 Stikla pudele, 10 ml -
V/DCP/15/0002-03 50 µg/ml 1 Stikla pudele, 15 ml -
V/DCP/15/0002-04 50 µg/ml 1 Stikla pudele, 25 ml -
V/DCP/15/0002-05 50 µg/ml 1 Stikla pudele, 50 ml -
TETRAVET LA 200 mg/ml V/NRP/98/0779 Ceva Sante Animale', Francija QJ01AA06 cattle; pigs; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Oxytetracycline
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale., Francija
Date of authorisation/renewal: 27-Sep-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Apr-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/98/0779-01 200 mg/ml 1 Plastikāta flakons, 100 ml -
V/NRP/98/0779-02 200 mg/ml 1 Plastikāta flakons, 250 ml -
V/NRP/98/0779-03 200 mg/ml 1 Plastikāta flakons, 50 ml -
V/NRP/98/0779-04 200 mg/ml 1 Plastikāta flakons, 500 ml -
Biocan Novel Puppy - V/DCP/17/0004 Bioveta, a.s., Čehija QI07AD03 dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Canine Distemper virus, strain CDV Bio 11/A,Canine Parvovirus Type 2, strain CPV-2b-Bio 12/B
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 27-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0004-01 5 Stikla flakons, 1 deva -
V/DCP/17/0004-02 10 Stikla flakons, 1 deva -
V/DCP/17/0004-03 25 Stikla flakons, 1 deva -
Vetmedin 1.5 mg/ml V/DCP/25/0008 Boehringer Ingelheim Pharma GmbH & Co. KG, Vācija QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: Oral solution
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Vetmedica GmbH, Vācija
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0008-01 1 Stikla pudelīte (dzintarkrāsas), 50 ml -
Lidor 20 mg/ml V/DCP/18/0003 VetViva Richter GmbH , Austrija QN01BB02 horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Lidocaine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0003-01 20 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/18/0003-02 20 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/18/0003-03 20 mg/ml 1 Stikla flakons, 250 ml -
V/DCP/18/0003-04 20 mg/ml 5 Stikla flakons, 50 ml -
V/DCP/18/0003-05 20 mg/ml 5 Stikla flakons, 100 ml -
Marbogen Complex - V/DCP/16/0026 Alphavet Zrt., Ungārija QS02AA30 dogs Vairāk

Medicinal product information

Pharmaceutical form: ear drops, solution
International name (active substance): Ketoconazole, Gentamicin sulphate, Marbofloxacin, Prednisolone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alphavet Zrt, Ungārija
Date of authorisation/renewal: 23-Sep-2021
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Jan-2025)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (16-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/16/0026-01 1 ZBPE pudele, 10 ml -

3081 record

© Food and veterinary service · 2026 Cookies policy